| Overview |
| bsm-62731r-apc-Cy5.5-100ul |
| TNFAIP8 Recombinant Antibody, APC-Cy5.5 Conjugated |
| WB |
| Human |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TNFAIP8 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 25816 |
| O95379 |
| Cytoplasm |
| NDED; SCCS2; TNFAIP8. |
| Acts as a negative mediator of apoptosis and may play a role in tumor progression. Suppresses the TNF-mediated apoptosis by inhibiting caspase-8 activity but not the processing of procaspase-8, subsequently resulting in inhibition of BID cleavage and caspase-3 activation. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz